Stroke Patients Benefit from Using AI

Article

Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform.

Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform than patients who received treatment normally. The AI platform used software algorithms on smartphones to confirm patient identity, medication and medication ingestion.

Read the full release here

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.